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Abstract
Background: Hominis Placenta (HP) known as a restorative medicine in Traditional Chinese Medicine (TCM), has
been widely applied in the clinics of Korea and China as an anti-aging agent to enhance the regeneration of
tissue. This study was conducted to investigate whether topical treatment of HP promotes hair regrowth in
the animal model.
Methods: The dorsal hairs of 8-week-old C57BL/6 mice were depilated to synchronize hair follicles to the anagen
phase. HP was applied topically once a day for 15 days. Hair growth was evaluated visually and microscopically. The
incorporation of bromodeoxyuridine (BrdU) and expression of proliferating cell nuclear antigen (PCNA), fibroblast
growth factor-7 (FGF-7) in dorsal skin tissue was examined by immunohistochemical analysis. Reverse transcription
polymerase chain reaction (RT-PCR) was used to measure the mRNA expression of FGF-7.
Results: HP exhibited potent hair growth-promoting activity in C57BL/6 mice. Gross examination indicated that HP
markedly increased hair regrowth as well as hair density and diameter. Histologic analysis showed that HP treatment
enhanced the anagen induction of hair follicles.
Immunohistochemical analysis revealed that BrdU incorporation and the expressions of PCNA were increased by
treatment of HP. HP treatment significantly increased the expression of FGF-7, which plays pivotal roles to maintain
anagen phase both protein and mRNA levels.
Conclusions: Taken together, our results indicate that HP has a potent hair growth-promoting activity; therefore, it
may be a good candidate for the treatment of alopecia.
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Background
The number of patients with alopecia is constantly in-
creasing because of the stressful modern lifestyle. In a
vast majority of cases, hair loss is attributable to hor-
mones and genetic factors [1, 2]; however, other factors,
such as autoimmune diseases, medications, and physio-
logic and psychological stresses have been linked to hair
loss [3–5]. These causative factors can alter the hair fol-
licle cycle.
Humans have about 5 million hair follicles at birth and
new follicles do not develop after birth [6]. Each hair
follicle, which produce hair shafts, undergo successive
cycles consisting of anagen (growing phase), catagen
(transitional phase), and telogen (resting phase). This
cycling occurs over the lifetime of the individual. Initi-
ation and progression of the hair follicle cycle are deter-
mined by intercellular communications between the
dermis and surface epithelium [7]. However, the com-
plex molecular interactions between the cells of the hair
follicle are not fully understood and the exact cause of
alopecia has not been elucidated [8].
Androgenic alopecia (AA) which is the most common
form of hair loss in men is characterized by thinning
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and visible loss of frontal hair. Under the influence of
dihydrotestosterone (DHT), terminal hair follicles grad-
ually change to miniaturized follicles. Hair follicular
miniaturization arises as a consequence of progressive
shortening of the duration of successive anagen [9].
Therefore, extension of anagen phase could be a good
strategy for the treatment of hair loss such as AA.
Hominis placenta (HP) has been used in Korea and
China to improve general well-being. Since the 1950s,
HP has been used as therapeutic agent. By stimulation
of liver regeneration, and controlling of endocrine sys-
tem, HP has been applied to the liver diseases [10], and
climacteric symptoms [11]. In addition, placenta extract
was known to have antioxidant, anti-inflammatory,
wound healing, and nerve growth-promoting effects
[12–15]. Therefore, it is possible that the various effects
of HP could influence the hair growth cycle.
One clinical study has already drawn attention to the
hair-growth promoting effects of placental extract [16].
More recently, there was another report about hair
growth promoting effects of cow placenta [17]. In this
study, we investigated the hair growth-promoting effect




Human placental extracts was provided from the Korean
Pharmacopuncture Institute (Seoul, Korea). Primary
antibodies specific for bromodeoxyuridine (BrdU), pro-
liferating cell nuclear antigen (PCNA), fibroblast growth
factor-7 (FGF-7), ß-actin were purchased from Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Bio-
tinylated goat anti-mouse immunoglobulin G (IgG) and
avidin-biotin peroxidase complex were purchased from
Vector Laboratories, Inc. (Burlingame, CA, USA). HRP-
linked anti-mouse Ig G antibody was purchased from GE
Healthcare Life Science (Pittsburgh, PA, USA). 3-3'diami-
nobenzidine, PBS solution, and hydrogen peroxide were
purchased from Sigma-Aldrich Co. (Youngin, Korea). Tri-
zol reagent and a reverse transcriptase-polymerase chain
reaction (RT-PCR) kit were purchased from Invitrogen
(Carlslab, CA, USA) and Bioneer Co. (Daejeon, Korea),
respectively.
Animals and in vivo hair growth activity
Seven-week-old male C57BL/6 mice were purchased
from Samtaco Bio Korea, Ltd. (Osan, Korea) and allowed
to adapt to the new environment for one week. The
mice were housed in certified, standard laboratory cages
and were provided with food and water ad libitum prior
to the experiment. Amount of foods that consumed by
one mouse per one week was about 42 g, and the
amount of drinking water in the same condition was
about 60 ml. Fifteen mice were divided into the follow-
ing three groups (5 mice per group): normal saline-, 5 %
minoxidil-, and HP-treated groups. The animal protocol
used in this study was reviewed by the Pusan National
University-Institutional Animal Care and Use Commit-
tee (PNU-IACUC) according to their ethical and scien-
tific procedures and was approved (Approval Number
PNU-2014-0581).
This study was designed according to the guidelines of
the Korean Food and Drug Administration (KFDA) to
evaluate hair growth promoting efficacy. The dorsal
hairs of 8-week-old C57BL/6 mice, with hair follicles in
the telogen phase of the hair growth cycle, were depi-
lated to synchronize hair follicle growth to the anagen
phase. One day after depilation, the mice were topically
treated with normal saline, 5 % minoxidil, or HP once a
day for 15 days (Fig. 1). Hair growth and thickness in
the depilated dorsal skin lesions were measured by der-
moscopy (Sometech, Inc., Seoul, Korea).
Skin histology
C57BL/6 mice were euthanized at 16th day after depil-
ation. Dorsal depilated skin tissues were collected from
the mice and fixed for 24 h at room temperature in
Fig. 1 Experimental scheme. Dorsal hairs of 8-week-old C57BL/6 mice, which were in the telogen phase of the hair cycle, were depilated to synchronize
anagen induction. The mice were divided into following three groups: group 1, normal saline-treated negative control; group 2, 5 % minoxidil-treated
positive control; group 3, Hominis Placenta (HP)-treated experimental group (n= 5 per group). Each agent were topically applied from the 1st to the 15th
day after hair depilation. Bromodeoxyuridine (BrdU) was administered twice a day on the 1st, 2nd, and the 3rd day after depilation. Depilated dorsal skin
lesions were collected at the 16th day after depilation and stained with hematoxylin and eosin. ●, Topical treatment with normal saline, 5 %
minoxidil, or HP
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Bouin’s solution. After dehydration, the skin tissues were
embedded in paraffin, cut into 7-μm-thick sections, and
placed onto glass slides. The slides were de-paraffinized
with xylene and stained with hematoxylin and eosin
(H&E). Processed skin tissues were examined by light
microscopy (Carl Zeiss, Germany).
Immunohistochemistry
BrdU, which is commonly used to label proliferating
cells in tissue sections [18], was injected intraperitone-
ally at 50 μg/g b.w. twice daily for three consecutive days
after hair depilation as described in a previous study
[19]. Dorsal skin tissues were collected 16 days after the
first treatment and subjected to immunostaining. Perme-
abilized tissue sections were incubated with the follow-
ing antibodies by using the dilutions indicated in the
manufacturer’s instructions: mouse anti-BrdU (1:200),
anti-PCNA (1:1000), and anti-FGF-7 (1:200). After the
primary antibody incubation, skin tissues were incubated
with biotinylated goat anti-mouse IgG in a moisture
chamber for 30 min. After washing, the tissues were in-
cubated with HRP-conjugated avidin-biotin complex.
After two more washing steps, the tissues were incu-
bated with 30 mg of 3-3′diaminobenzidine dissolved in
150 mL of 0.1 M PBS solution for another 5 min, and
then 0.005 % hydrogen peroxide was added for 15 min
to develop the color. Immunoreactivity was examined by
light microscopy.
RT-PCR
Total RNA was isolated using TRIzol reagent, and com-
plementary DNA (cDNA) was synthesized using Accu-
Power RT PreMix (Bioneer, Daejon, Korea) according to
the manufacturer’s instructions. Specific DNA sequences
were amplified with AccuPower PCR PreMix (Bioneer,
Daejon, Korea). The oligonucleotide primer sequences were
as follows: FGF-7, forward 5′-AGATCATGCTTCCACCT
CGT-3′ and reverse 5′-TGGGTCCCTTTCACTTTGCC-
3′; GAPDH, forward 5′-GGAGCCAAAAGGGTCATCA
T-3′ and reverse 5′-GTGATGGCATGGACTGTGGT-3′.
Amplified products were separated on 1.0 % agarose gels
and analyzed under ultraviolet light. Images were captured
using a GelDoc-It TS Imaging System (UVP, LLC, Upland,
CA, USA).
Western blot
To isolate proteins, skin tissues were lysed by RIPA buf-
fer (0.1 % SDS, 1 % NP-40, 50 mM Tris, pH7.5, 150 mM
NaCl, 50 mM NaF, 1 mM EDTA). Protein concentration
of cell lysate was determined by Bradford method. After
denaturation of protein at 100 °C for 5 min, 10 μg of
proteins were loaded on the 10 % polyacrylamide gel,
then separated by electrophoresis. After separation, the
proteins were transferred to the polyvinylidene difluoride
(PVDF) membrane. The membrane was blocked by 5 %
non-fat milk in TBST for 1 h at room temperature. After
blocking, the membrane was washed by TBST 3 times,
then incubated with 1: 500 diluted mouse monoclonal
anti-FGF7 antibody at 4 °C for overnight. The next day,
the membrane was washed 3 times by TBST, then incu-
bated with anti-mouse Ig G HRP-linked antibody for
1 h, at room temperature. After finishing another 3
times of washing, enhanced chemilumescent (ECL) sub-
strates were added to the membrane for the detection of
antibody. Images were captured by using Amersham
Imager 600 (Pittsburgh, PA, USA).
Statistical analyses
Data are expressed as the mean ± standard deviation
(SD). Statistical differences between means were de-
termined by one-way analysis of variance (ANOVA)
for repeated measures. P values less than 0.05 were
considered significant.
Results
HP promotes hair re-growth on the depilated skin lesions
of C57BL/6 mice
We tested the hair growth-promoting activity of HP. HP
was applied topically daily onto the depilated dorsal le-
sions of C57BL/6 mice. Normal saline, 5 % minoxidil
were used as the negative and positive control, respect-
ively (Fig. 2, left and middle panel). HP promoted hair
re-growth to a similar extent as minoxidil (Fig. 2, right
panel). The skin color of HP-treated mice changed from
pale to dark gray/black, indicating initiation of anagen.
HP also increases hair density and thickness in C57BL/6 mice
Hair density and thickness were examined by dermo-
scopy. Figure 3a shows dermoscopic images of hair
density and diameter at the 14th and 16th day after depil-
ation. Hair density was higher in HP- or 5 % minoxidil-
treated mice than in normal saline-treated mice. A sig-
nificant difference in hair density was observed at day
14; however, this difference decreased by at day 16
(Fig. 3a, b). Hair diameter was also larger in the HP- and
5 % minoxidil-treated mice than in the mice treated with
normal saline (Fig. 3a, c).
HP enhanced the anagen induction and the cellular
proliferation of hair follicle
Histological examination showed that hair follicles in
the normal saline-treated mice resided in the dermis,
indicating that they had not fully developed to anagen
(Fig. 4, upper left). However, the hair shafts of follicles
in the skin of HP-treated mice extended through the
epidermis, indicating that they were fully developed to
anagen IV phase (Fig. 4, upper right). Immunohisto-
chemical analysis confirmed that BrdU incorporation
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was prominently increased by HP (Fig. 4, middle right).
Strongly positive reactions against BrdU were observed
in the bulge, inner and outer root sheath, panniculus
carnosus, and epidermal epithelium, indicating that HP
induced active cell division in the hair follicle. HP also
increased the expression of PCNA in the hair bulb, and
in the inner and outer root sheath (Fig. 4, lower right,
large box).
HP upregulates the expression of fibroblast growth
factor-7 (FGF-7) involved in anagen development
HP increased the expression of FGF-7 in the epidermis,
and inner and outer root sheath, to a degree comparable
to minoxidil treatment (Fig. 5a, right, large box). HP also
increased the mRNA and protein expression of FGF-7,
key molecule in tissue repair and anagen induction in
the dorsal skin lesions of C57BL/6 mice (Fig. 5b).
Discussion
Placenta exerts critical roles in the development of fetus
by exchanging nutrient, oxygen, waste products between
mother and fetus, producing hormones which support
the pregnancy. Placenta contains various bioactive
substances including nucleic acid, amino acid [20]. Es-
sential and non-essential amino acids contained in pla-
centa were reported to be essential for the making fetal
proteins [21]. Placenta has been used for the medical
purpose since thousand years ago, in Eastern countries.
In Traditional Chinese Medicine, human placenta (HP)
has been used to enhance the vital essence [22]. Now-
adays HP is considered as a source of cells with stem cell
potential and could be able to applicate the tissue injur-
ies [23]. Although a number of clinical studies about the
beneficial effects of placenta extracts has been reported
[24–27], the vast majority of the functional studies of
the placental extracts was focused on it’s wound healing
potential in the tissue repairing process [28–31]. Pla-
centa extract was reported to increase the expression of
bFGF and TGF-β1, two key factors involved in wound
healing in the rat wound skin [14]. Aqueous extract of
placenta was known to contain various peptides respon-
sible for tissue regeneration [29]. Angiogenesis is a key
process in the wound healing. New vessels deliver oxy-
gen and nutrients to the injured lesions thereby facilitat-
ing tissue regeneration [32]. Angiogenic factor which
suggested to be peptide was extracted from placenta
Fig. 2 Gross observation of hair re-growth in C57BL/6 mice. At the 14th and 16th days after depilation, skin color and hair growth of the depilated skin
lesions were observed. Each group of mice has been topically treated with normal saline or 5 % minoxidil or HP once a day for consecutive 15 days
respectively. Depilated dorsal skin lesions were photographed at the 14th and 16th day after depilation. Hair regrowth, as well as skin darkness, was
increased in mice treated with HP as compared to normal control mice
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[33]. Placenta extracts also induced nitric oxide (NO), a
vasodilator in the mouse peritoneal macrophages [34].
More recently, placenta extract was also reported to
inhibit Proteinase K, a microbial protease, thereby pos-
sibly prevent excessive proteolysis observed in bacterial
infections [35].
Besides the wound healing, hair follicle cycle repre-
sents the other physiological regenerating event occur-
ring in the skin. Growth factors involved in the wound
healing are also involved in the hair follicle cycle [7].
Therefore, regenerative potential of placenta extract
could also influence the hair cycle. Among the bioactive
substance contained in placenta extract, several amino
acids were known to positively influence hair growth.
Arginine, a precursor of nitric oxide, plays an important
role in skin angiogenesis [36]. Glutamine delivers
sulphur which is necessary for hair growth [37]. Women
with increased hair shedding responded to l-lysine and
iron therapy [38].
Hair follicles undergo successive growth, regression,
rest, and shedding over the life time. Hair follicular cells
including mesenchymal cells of dermal papilla and over-
lying epithelial cells which is responsible for making hair
shaft only proliferate during anagen phase [6]. Therefore,
length and thickness of each hair shafts largely determined
by the duration of anagen. Hair follicle miniaturization,
one of the most characteristic features of androgenic alo-
pecia, was due to the progressive shortening of anagen in
response to DHT [2]. Therefore, a rational strategy for the
treatment of androgenic alopecia is to inhibit DHT activity
or to prolong the duration of the anagen phase. Transition
from anagen to categen is regulated by various molecules
released from hair follicular cells. Among them Fibroblast
growth factor-7 (FGF-7) was known to play a pivotal role
in the reentering of hair follicle to the next anagen phase
[7, 39]. FGF-7, also known as keratinocyte growth factor,
which plays important role in the regulation of prolifera-
tion in epithelial tissues [40], also protects the hair follicle
from cytotoxic agents or UV irradiation [41, 42].
In this study, we found that HP treatment accelerated
anagen induction in the hair follicles of C57BL/6 mice.
Gross observation showed that the capacity of HP to
enhance hair growth in C57BL/6 mice was comparable
to that of minoxidil. Histological examination revealed
that hair follicles in normal saline-treated mice were
smaller and less developed than those in minoxidil- or
HP-treated mice. This observation is consistent with the
gross examination indicating that HP has the potential to
Fig. 3 Dermoscopic observation of hair regrowth in C57BL/6 mice. Dorsal skins of mice were photographed by dermoscopy at the 14th and 16th day
after depilation. Hair density was expressed as the number of hairs per unit area. Compared to the skin of the mice in the normal saline-treated control
group (Con), the skin of the mice in the 5 % minoxidil (Min)- or HP-treated group had increased hair density and diameter (a). Hair density and hair
diameter was greater in HP treated group than normal control group (b, c). Original Magnification: X100, X400. Values represent the mean ± standard
deviation. ***P < 0.001, compared to control
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enhance anagen induction. As expected, hair density and
diameter were also increased by the treatment of HP.
To evaluate the effect of HP on hair matrix cell prolif-
eration during anagen, we examined the pattern of BrdU
incorporation and PCNA expression. High levels of
BrdU incorporation were observed in the dermal papilla,
outer layer of the hair shaft, and connective tissue.
PCNA was highly expressed in the lower regions of the
hair matrix, indicating that HP treatment induced DNA
synthesis (Fig. 4, lower left). This finding is consistent
Fig. 4 Microscopic observation of hair follicle in C57BL/6 mice. Histologic examination reveals hair follicle development in C57BL/6 mice treated
with normal saline or MINX or HP for 15 days. Dorsal skin sections were stained with hematoxylin and eosin. Immunohistochemical staining were
performed to examine the expression of BrdU and PCNA. MINX: minoxidil; HP: Hominis placenta; Original magnification: X100, large box: X200
Fig. 5 HP upregulates the expression of FGF-7 involved in anagen development Dorsal skins were collected from C57BL/6 mice treated with normal saline
(Con), 5 % minoxidil (MINX), or HP for 15 days. Immunohistochemical analysis of hair follicles against FGF-7 was performed (a). Original magnification: X100,
large box: X200. RT-PCR and western blot method was used to determine the expression of FGF7 at the mRNA and protein level (b)
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with the previous observation that HP increases hair
diameter, because hair thickness is proportional to the
volume of the hair matrix.
It is well known that the hair cycle is regulated by
complex epithelial-mesenchymal interactions. A number
of growth factors in the dermal papilla and overlying
epithelial cells are known to interact with each other
during hair growth cycle progression [43]. FGF-7 plays a
pivotal role on the hair follicular cycle [44, 45]. We
found that FGF-7 expression was increased in the outer
layer of the hair shaft and surface epithelium by the
treatment of HP. Increased expression of FGF-7 in the
skin tissues both mRNA and protein level, determined
by RT-PCR and western blot respectively.
We showed that topical treatment with HP induced
robust hair re-growth in C57BL/6 mice owing to prolif-
eration of hair matrix cells and upregulation of FGF-7.
This study helps to understand the basic mechanism
through which HP acts on hair follicle development. In
particular, increased expression of FGF-7 by HP explains
it’s positive effects on the anagen induction.
Conclusions
HP has a potent hair growth-promoting activity; there-
fore, it may be a good candidate for the treatment of
alopecia.
Abbreviations
AA, androgenic alopecia; BrdU, bromodeoxyuridine; DHT, dihydrotestosterone;
ECL, enhanced chemilumescent; FGF-7, fibroblast growth factor-7; HP, Hominis
Placenta; PCNA, proliferating cell nuclear antigen; PVDF, polyvinylidene difluor-
ide; RT-PCR, reverse transcriptase-polymerase chain reaction
Acknowledgments
This study was supported by the National Research Foundation of Korea
(NRF) grant funded by the Korea government (MSIP) (2014R1A5A2009936).
Funding
This study was supported by the National Research Foundation of Korea
(NRF) grant funded by the Korea government (MSIP) (2014R1A5A2009936).
Availability of data and materials
The datasets supporting the conclusions of this article are included within
the article.
Authors’ contributions
HSS and HSJ designed the study and HSJ wrote the manuscript. DJL and
JHC conducted animal study. CHL and HRK contributed to microscopic data
analysis. JEK and KTH helped the molecular analyses and improved the style
of written English. MHJ helped to response the reviewer’s comment and
wrote parts of discussion. BJK provided the western data during revision. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
This information is not relevant.
Ethics approval and consent to participate
This information is not relevant.
Author details
1Department of Ophthalmology, Otolaryngology and Dermatology, Korean
Medicine Hospital, Pusan National University, Yangsan, Republic of Korea.
2Department of Clinical Medicine, Graduate School, Kyung Hee University,
Seoul, Republic of Korea. 3Chung Jaeho Traditional Korean Medical Clinic,
Seoul, Republic of Korea. 4Department of Anatomy, College of Korean
Medicine, Woosuk University, Wanju, Republic of Korea. 5College of food &
biotechnology, Woosuk University, Wanju, Republic of Korea. 6Department of
Pathology, College of Korean Medicine, Dongguk University, Goyang,
Republic of Korea. 7Division of Longevity and Biofunctional Medicine, School
of Korean Medicine, Pusan National University, Yangsan, Republic of Korea.
8Healthy Aging Korean Medical Research Center, School of Korean Medicine,
Pusan National University, Yangsan, Republic of Korea. 9Division of Applied
Medicine, School of Korean Medicine, Pusan National University, Yangsan,
Republic of Korea.
Received: 7 July 2015 Accepted: 15 June 2016
References
1. Ellis JA, Stebbing M, Harrap SB. Polymorphism of the androgen receptor
gene is associated with male pattern baldness. J Invest Dermatol. 2001;
116(3):452–5.
2. Kaufman KD. Androgens and alopecia. Mol Cell Endocrinol. 2002;198(1-2):89–95.
3. Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: stress and the
underestimated psychosocial impact of telogen effluvium and androgenetic
alopecia. J Invest Dermatol. 2004;123(3):455–7.
4. Gilhar A, Keren A, Shemer A, d'Ovidio R, Ullmann Y, Paus R. Autoimmune
Disease Induction in a Healthy Human Organ: A Humanized Mouse Model
of Alopecia Areata. J Invest Dermatol. 2013;133(3):844–7.
5. Botchkarev VA, Komarova EA, Siebenhaar F, Botchkareva NV, Komarov PG,
Maurer M, Gilchrest BA, Gudkov AV. p53 is essential for chemotherapy-
induced hair loss. Cancer Res. 2000;60(18):5002–6.
6. Paus R, Cotsarelis G. The biology of hair follicles. New Engl J Med. 1999;
341(7):491–7.
7. Stenn KS, Paus R. Controls of hair follicle cycling. Physiol Rev. 2001;81(1):449–94.
8. Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair
growth. Br J Dermatol. 2004;150(2):186–94.
9. Price VH. Treatment of hair loss. New Engl J Med. 1999;341(13):964–73.
10. Zhao L, Li JH, Zhu DZ, Ji BP. Principal component analysis of nutrients in
five varieties of velvet antler (Cornu Cervi Pantotrichum). Guang pu. 2010;
30(9):2571–5.
11. Wang J, He G, Fu W, Su B, Wang W, Zhang Y, Lu Y, He M, Zhu Z. Extraction
and sequencing of trace DNA from cornu Cervi pantotrichum. China J
Chinese Meter Med. 1997;22(10):579–83. 638.
12. Zhang S, Li F. Determination of amino acids in cornu cervi pantotrichum of
different specifications. China J Chinese Meter Med. 2013;38(12):1919–23.
13. Liu Y, Zhang GJ, Sun SQ, Noda I. Study on similar traditional Chinese
medicines cornu Cervi pantotrichum, cornu Cervi and cornu Cervi
degelatinatum by FT-IR and 2D-IR correlation spectroscopy. J Pharmaceut
Biomed. 2010;52(4):631–5.
14. Wu CH, Chang GY, Chang WC, Hsu CT, Chen RS. Wound healing effects of
porcine placental extracts on rats with thermal injury. Br J Dermatol. 2003;
148(2):236–45.
15. Seo TB, Han IS, Yoon JH, Seol IC, Kim YS, Jo HK, et al. Growth-promoting
activity of Hominis Placenta extract on regenerating sciatic nerve. Acta
Pharmacol Sin. 2006;27(1):50–8.
16. Hauser GA. Placental Extract Injections in the Treatment of Loss of Hair in
Women. Int J Tissue React. 1982;4(2):159–63.
17. Zhang D, Lijuan G, Jingjie L, Zheng L, Wang C, Wang Z, et al. Cow placenta
extract promotes murine hair growth through enhancing the insulin - like
growth factor-1. Indian J Dermatol. 2011;56(1):14–8.
18. Nowakowski RS, Lewin SB, Miller MW. Bromodeoxyuridine immunohistochemical
determination of the lengths of the cell cycle and the DNA-synthetic phase for
an anatomically defined population. J Neurocytol. 1989;18(3):311–8.
19. Ito M, Kizawa K, Hamada K, Cotsarelis G. Hair follicle stem cells in the lower
bulge form the secondary germ, a biochemically distinct but functionally
equivalent progenitor cell population, at the termination of catagen.
Differentiation. 2004;72(9-10):548–57.
20. Shibasaki T, Odagiri E, Shizume K, Ling N. Corticotropin-Releasing Factor-Like
Activity in Human Placental Extracts. J Clin Endocr Metab. 1982;55(2):384–6.
Seo et al. BMC Complementary and Alternative Medicine  (2016) 16:187 Page 7 of 8
21. Cleal JK, Lewis RM. The mechanisms and regulation of placental amino acid
transport to the human foetus. J Neuroendocrinol. 2008;20(4):419–26.
22. Yang GQ, Zou XH. Research Advances on Chemical Compositions,
Pharmacological Effect and Clinic Application of Placenta and Its Extract
from Human and Animals. J Shenyang Agri U. 2003;34:150-154.
23. Lange-Consiglio A, Corradetti B, Bizzaro D, Magatti M, Ressel L, Tassan S, et al.
Characterization and potential applications of progenitor-like cells isolated
from horse amniotic membrane. J Tissue Eng Regen M. 2012;6(8):622–35.
24. Kaushal V, Verma K, Manocha S, Hooda HS, Das BP. Clinical evaluation of
human placental extract (placentrex) in radiation-induced oral mucositis. Int
J Tissue React. 2001;23(3):105–10.
25. Chandanwale A, Langade D, Mohod V, Sinha S, Ramteke A, Bakhshi GD, et
al. Comparative evaluation of human placental extract for its healing
potential in surgical wounds after orthopaedic surgery: an open,
randomised, comparative study. J Indian Med Assoc. 2008;106(6):405–8.
26. Hijikata Y, Kano T, Xi L. Treatment for intractable anemia with the traditional
Chinese medicines Hominis Placenta and Cervi Cornus Colla (deer antler
glue). Inter J Gen Med. 2009;2:83–90.
27. Choi JY, Lee K, Lee SM, Yoo SH, Hwang SG, Lee SW, et al. Efficacy and safety of
human placental extract for alcoholic and nonalcoholic steatohepatitis: an open-
label, randomized, comparative study. Biol Pharm Bull. 2014;37(12):1853–9.
28. Datta P, Bhattacharyya D. Spectroscopic and chromatographic evidences of
NADPH in human placental extract used as wound healer. J Pharmaceut
Biomed. 2004;34(5):1091–8.
29. Chakraborty PD, Bhattacharyya D. Isolation of fibronectin type III like
peptide from human placental extract used as wound healer. J Chromatogr
B. 2005;818(1):67–73.
30. Chakraborty PD, De D, Bandyopadhyay S, Bhattacharyya D. Human aqueous
placental extract as a wound healer. J Wound Care. 2009;18(11):462. 464-467.
31. De D, Chakraborty PD, Bhattacharyya D. Analysis of free and bound NADPH
in aqueous extract of human placenta used as wound healer. J Chromatogr
B. 2009;877(24):2435–42.
32. Logan A, Weatherhead B. Effects of alpha-melanocyte-stimulating hormone
and [8-arginine]-vasotocin upon melanogenesis in hair follicle melanocytes
in vitro. J Endocrinol. 1981;91(3):501–7.
33. Burgos H. Angiogenic factor from human term placenta. Purification and
partial characterization. Eur J Clin Invest. 1986;16(6):486–93.
34. Chakraborty PD, Bhattacharyya D, Pal S, Ali N. In vitro induction of nitric
oxide by mouse peritoneal macrophages treated with human placental
extract. Int Immunopharmacol. 2006;6(1):100–7.
35. Sharma K, Mukherjee C, Roy S, De D, Bhattacharyya D. Human placental
extract mediated inhibition of proteinase K: implications of heparin and
glycoproteins in wound physiology. J Cell Physiol. 2014;229(9):1212–23.
36. Joshi M, Fuller LR, Batchelor GC. L-arginine metabolites regulate DNA
synthesis and nitric oxide synthase activity in cultured human dermal
microvascular endothelial cells–potential positive and negative regulators of
angiogenesis derived from L-arginine. Cancer Invest. 1999;17(4):235–44.
37. Stuehr DJ, Gross SS, Sakuma I, Levi R, Nathan CF. Activated murine
macrophages secrete a metabolite of arginine with the bioactivity of
endothelium-derived relaxing factor and the chemical reactivity of nitric
oxide. J Exp Med. 1989;169(3):1011–20.
38. Rushton DH, Ramsay ID, James KC, Norris MJ, Gilkes JJH. Biochemical and
Trichological Characterization of Diffuse Alopecia in Women. Br J Dermatol.
1990;123(2):187–97.
39. Werner S, Grose R. Regulation of wound healing by growth factors and
cytokines. Physiol Rev. 2003;83(3):835–70.
40. Housley RM, Morris CF, Boyle W, Ring B, Biltz R, Tarpley JE, et al. Keratinocyte
growth factor induces proliferation of hepatocytes and epithelial cells
throughout the rat gastrointestinal tract. J Clin Invest. 1994;94(5):1764–77.
41. Booth C, Potten CS. Keratinocyte growth factor increases hair follicle survival
following cytotoxic insult. J Invest Dermatol. 2000;114(4):667–73.
42. Braun S, Krampert M, Bodo E, Kumin A, Born-Berclaz C, Paus R, et al.
Keratinocyte growth factor protects epidermis and hair follicles from cell
death induced by UV irradiation, chemotherapeutic or cytotoxic agents. J
Cell Sci. 2006;119(23):4841–9.
43. Botchkarev VA, Kishimoto J. Molecular control of epithelial-mesenchymal
interactions during hair follicle cycling. J Invest Derm Symp P. 2003;8(1):46–55.
44. Rosenquist TA, Martin GR. Fibroblast growth factor signalling in the hair
growth cycle: expression of the fibroblast growth factor receptor and ligand
genes in the murine hair follicle. Dev Dynam. 1996;205(4):379–86.
45. Kawano M, Komi-Kuramochi A, Asada M, Suzuki M, Oki J, Jiang J, et al.
Comprehensive analysis of FGF and FGFR expression in skin: FGF18 is highly
expressed in hair follicles and capable of inducing anagen from telogen
stage hair follicles. J Invest Dermatol. 2005;124(5):877–85.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Seo et al. BMC Complementary and Alternative Medicine  (2016) 16:187 Page 8 of 8
